PRTA — PROTHENA CORP PUBLIC LTD CO

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1559053 ·
Last close
$8.61
Market Cap
$442.01M
52W High
$11.80
52W Low
$7.73
ADV30
484,873
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,010,000 — -18,687,000 -18,583,000 302,579,000 288,193,000 15,688,000
Mar 2026 51,084,000 — 25,791,000 32,721,000 349,894,000 329,462,000 37,278,000
Dec 2025 21,000 — -27,211,000 -21,589,000 326,804,000 307,531,000 46,330,000
Sep 2025 2,415,000 — -39,761,000 -36,541,000 352,628,000 330,843,000 57,639,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-60,049,000
Investing CF
$-662,000
Financing CF
$-22,531,000
CapEx
$-181,000
Dividends Paid
—
Buybacks
$-22,531,000
EPS Diluted TTM
$-0.84
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,332,295,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-59,868,000
Pretax Income TTM
$-44,350,000
Interest Exp TTM
—
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$54,530,000
EBITDA
$-59,040,000
Free Cash Flow
$-54,222,500
Enterprise Value
$177,237,184
Total Cash
$288,192,992
Total Debt
$6,991,000
Shares Out
51,336,974
Trailing EPS
$-0.82
Book Value
$5.54
ROE
-14.4%
ROA
-10.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 9,684,000 -184,560,000 -244,092,000 326,804,000 46,330,000 280,474,000 -163,580,000
Dec 2024 135,157,000 -154,561,000 -122,310,000 547,108,000 60,182,000 486,926,000 -150,050,000
Dec 2023 91,370,000 -191,036,000 -147,028,000 696,382,000 135,017,000 561,365,000 -133,906,000
Dec 2022 53,905,000 -131,557,000 -116,949,000 758,035,000 135,993,000 622,042,000 -108,821,000

TTM Snapshot

Revenues TTM
$57,940,000
NetIncome TTM
$-151,176,000
OpCashFlow TTM
—
Assets (Latest)
$349,894,000
Forward EPS
$-1.52

Max Pain — expiry 2026-12-18

max pain strike: $9.00 · spot: $8.80 · call oi: 2,456 · put oi: 2,455
Expected Move to 2026-12-18: ±$1.55 (17.61%) — implied range $7.25 – $10.35 · ATM straddle on $9.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IBO IMPACT BIOMEDICAL INC. $443.15M $4.11 —
KMDA KAMADA LTD $448.70M $7.78 —
RZLT Rezolute, Inc. $448.79M $4.64 —
CTNM Contineum Therapeutics, Inc. $434.39M $13.18 —
DMAC DiaMedica Therapeutics Inc. $431.94M $8.01 —

News headlines (Yahoo Finance, 1h cache)

CRMD vs. PRTA: Which Stock Should Value Investors Buy Now?
2026-10-08 14:40 · Yahoo
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-09 20:05 · Yahoo
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
2026-08-06 23:10 · Yahoo
Prothena to Report Second Quarter 2026 Financial Results on August 6
2026-07-30 20:05 · Yahoo
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
2026-05-11 13:17 · Yahoo
KMDA or PRTA: Which Is the Better Value Stock Right Now?
2026-08-14 15:40 · Yahoo
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
2026-08-07 17:41 · Yahoo
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
2026-09-21 16:40 · Yahoo
Real Parkinson’s Disease Hope from Jupiter Neurosciences
2026-08-19 16:32 · Yahoo
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights
2026-08-06 20:05 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-10-06 13:53:53 2026-10-02 Scully William P 10% P - Purchase 8.57 100000 857240
2026-09-30 17:10:27 2026-09-29 Scully William P 10% P - Purchase 8.68 162000 1405674